Search research articles
Contact Us
Filters
Showing results (581-590 of 638) with videos related to
Page
of 64
Sort By:
The American Journal of Pathology
|
April 6, 2001
c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma
M Tokunou, T Niki, K Eguchi, et al.
British Journal of Cancer
|
February 14, 2013
Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
G Nishikawa, S Sekine, R Ogawa, et al.
European Journal of Gynaecological Oncology
|
September 23, 2015
Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients
T Yoshihama, T Chiyoda, F Kataoka, et al.
British Journal of Cancer
|
July 8, 2010
Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
M Tanioka, C Shimizu, K Yonemori, et al.
British Journal of Cancer
|
August 26, 2010
Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
N Hiraoka, Y Ino, S Sekine, et al.
American Journal of Hematology
|
January 10, 1998
Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure
N Kuribayashi, H Matsuzaki, H Hata, et al.
Japanese Journal of Cancer Research : Gann
|
March 1, 1996
Modifying influence of swine-serum-induced liver fibrosis on development of preneoplastic lesions in rat liver
S Wada, T Kato, M Mutai, et al.
British Journal of Cancer
|
September 5, 2013
Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay
T Osako, H Tsuda, R Horii, et al.
Breast Cancer (Tokyo, Japan)
|
January 16, 2002
Evaluation of HER2 status: for the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab)
S Umemura, G Sakamoto, H Sasano, et al.
Toxicologic Pathology
|
December 24, 1998
Histogenetic stereological reconstruction of rat basophilic, clear, and oncocytic neoplastic renal cell lesions using carbonic anhydrase type II-PAS double-stained sections
H Tsuda, T Iwase, K Matsumoto, et al.
Page
of 64
Search research articles
Search
Showing results (581-590 of 638) with videos related to
Sort By:
Page
of 64
The American Journal of Pathology
|
April 6, 2001
c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma
M Tokunou, T Niki, K Eguchi, et al.
British Journal of Cancer
|
February 14, 2013
Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms
G Nishikawa, S Sekine, R Ogawa, et al.
European Journal of Gynaecological Oncology
|
September 23, 2015
Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients
T Yoshihama, T Chiyoda, F Kataoka, et al.
British Journal of Cancer
|
July 8, 2010
Predictors of recurrence in breast cancer patients with a pathologic complete response after neoadjuvant chemotherapy
M Tanioka, C Shimizu, K Yonemori, et al.
British Journal of Cancer
|
August 26, 2010
Tumour necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation
N Hiraoka, Y Ino, S Sekine, et al.
American Journal of Hematology
|
January 10, 1998
Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure
N Kuribayashi, H Matsuzaki, H Hata, et al.
Japanese Journal of Cancer Research : Gann
|
March 1, 1996
Modifying influence of swine-serum-induced liver fibrosis on development of preneoplastic lesions in rat liver
S Wada, T Kato, M Mutai, et al.
British Journal of Cancer
|
September 5, 2013
Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay
T Osako, H Tsuda, R Horii, et al.
Breast Cancer (Tokyo, Japan)
|
January 16, 2002
Evaluation of HER2 status: for the treatment of metastatic breast cancers by humanized anti-HER2 Monoclonal antibody (trastuzumab) (Pathological committee for optimal use of trastuzumab)
S Umemura, G Sakamoto, H Sasano, et al.
Toxicologic Pathology
|
December 24, 1998
Histogenetic stereological reconstruction of rat basophilic, clear, and oncocytic neoplastic renal cell lesions using carbonic anhydrase type II-PAS double-stained sections
H Tsuda, T Iwase, K Matsumoto, et al.
Page
of 64